Sabyasachi Sen, MD, PhD
Washington DC VA Medical Center · GWU · Medical Faculty Associates
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sabyasachi Sen, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:43 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07155694 · Role of Finerenone in African American Veterans With Diabetic Kidney DiseaseWashington D.C. Veterans Affairs Medical Center · not yet recruiting · Diabetic Kidney Disease · principal investigator
- Ph4NCT03660683 · Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes MellitusSabyasachi Sen · terminated · Diabetes Mellitus, Type 2, Cardiovascular Diseases · principal investigator
- Ph4NCT02964585 · Role of Canagliflozin on CD34+ Cells in Patients With Type 2 DiabetesGeorge Washington University · completed · Type 2 Diabetes Mellitus · principal investigator
- Ph4NCT02467478 · Linagliptin's Effect on CD34+ Stem CellsGeorge Washington University · completed · Type 2 Diabetes, Impaired Renal Function · principal investigator
- N/ANCT01860599 · Effects of Aerobic Exercise in Patients With Pre-diabetesBaystate Medical Center · completed · Prediabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.